FDA Grants Breakthrough Therapy Designation to Belite Bio’s Tinlarebant for Stargardt Disease
A once-daily oral pill for Stargardt? Tinlarebant takes a big step with FDA breakthrough status. In a major step forward…
The Next-Gen Arsenal of Genomic Tools for IRDs and Other Eye Diseases Lighting Up ARVO 2025
Innovative genomic techniques on display at ARVO 2025 could slam the door shut on some of the biggest challenges in…
latest posts
